Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation
Jaerak Chang, … , Seongju Lee, Craig Blackstone
Jaerak Chang, … , Seongju Lee, Craig Blackstone
Published November 3, 2014
Citation Information: J Clin Invest. 2014;124(12):5249-5262. https://doi.org/10.1172/JCI77598.
View: Text | PDF
Research Article Neuroscience

Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation

  • Text
  • PDF
Abstract

Autophagy allows cells to adapt to changes in their environment by coordinating the degradation and recycling of cellular components and organelles to maintain homeostasis. Lysosomes are organelles critical for terminating autophagy via their fusion with mature autophagosomes to generate autolysosomes that degrade autophagic materials; therefore, maintenance of the lysosomal population is essential for autophagy-dependent cellular clearance. Here, we have demonstrated that the two most common autosomal recessive hereditary spastic paraplegia gene products, the SPG15 protein spastizin and the SPG11 protein spatacsin, are pivotal for autophagic lysosome reformation (ALR), a pathway that generates new lysosomes. Lysosomal targeting of spastizin required an intact FYVE domain, which binds phosphatidylinositol 3-phosphate. Loss of spastizin or spatacsin resulted in depletion of free lysosomes, which are competent to fuse with autophagosomes, and an accumulation of autolysosomes, reflecting a failure in ALR. Moreover, spastizin and spatacsin were essential components for the initiation of lysosomal tubulation. Together, these results link dysfunction of the autophagy/lysosomal biogenesis machinery to neurodegeneration.

Authors

Jaerak Chang, Seongju Lee, Craig Blackstone

×

Figure 1

Spastizin localizes to lysosomes through its FYVE domain.

Options: View larger image (or click on image) Download as PowerPoint
Spastizin localizes to lysosomes through its FYVE domain.
(A and B) HeLa...
(A and B) HeLa cells transiently expressing HA-spastizin were coimmunostained for HA-epitope (green) and either endogenous (A) LAMP1 or (B) CD63 (red). (C and D) HeLa cells were coimmunostained for endogenous spastizin (green) and either (C) LAMP1 or (D) CD63 (red). (E) HeLa cells were coimmunostained for either EEA1 or CI-MPR (red) with endogenous spastizin (green). (F) Skin fibroblasts derived from a control subject and a patient with SPG15 were coimmunostained for LAMP1 (red) and endogenous spastizin (green). (G) HeLa cells were transfected with wild-type or mutant HA-spastizin constructs as shown and coimmunostained for HA-epitope (green) and LAMP1 (red). Merged images are to the right in A–D and G. Boxed areas in the images in the top rows are enlarged in the bottom rows in A–D (original magnification, ×2.5), and boxed areas in the images in the left columns are enlarged in the right columns in E and F (original magnification, ×4). Scale bar: 10 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts